Shih-Ming Liao

The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study

Kuan-Lin Kuo, Shing‐Hwa Liu, Wei‐Chou Lin et al. · Cells · 2019 · 27 citations · Full text

Bladder Uc Treatment, Chemoprevention Strategy, Apoptosis +16

Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers: <i>in vitro</i> and <i>in vivo</i> study.

Chung‐Sheng Shi, Kuan-Lin Kuo, Wei‐Chou Lin et al. · PubMed · 2020 · 26 citations · Full text

Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway

Fu-Shun Hsu, June‐Tai Wu, Jing‐Yi Lin et al. · International Journal of Molecular Sciences · 2019 · 25 citations · Full text

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study

Fu-Shun Hsu, Wei‐Chou Lin, Kuan-Lin Kuo et al. · International Journal of Molecular Sciences · 2021 · 25 citations · Full text

C-myc Expression, Cancer Biology, Tumor Biology +17

MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study.

Wei‐Chou Lin, Kuan-Lin Kuo, Chung‐Sheng Shi et al. · PubMed · 2015 · 24 citations

Antitumor Activity, Cc Xenografts, Immunology +17